GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Abionyx Pharma (LTS:0RAG) » Definitions » PB Ratio

Abionyx Pharma (LTS:0RAG) PB Ratio : 4.20 (As of Oct. 31, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Abionyx Pharma PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-10-31), Abionyx Pharma's share price is €1.234. Abionyx Pharma's Book Value per Share for the quarter that ended in Jun. 2024 was €0.29. Hence, Abionyx Pharma's PB Ratio of today is 4.20.

The historical rank and industry rank for Abionyx Pharma's PB Ratio or its related term are showing as below:

LTS:0RAG' s PB Ratio Range Over the Past 10 Years
Min: 1.03   Med: 4.76   Max: 13.79
Current: 4.24

During the past 11 years, Abionyx Pharma's highest PB Ratio was 13.79. The lowest was 1.03. And the median was 4.76.

LTS:0RAG's PB Ratio is ranked worse than
70.76% of 1269 companies
in the Biotechnology industry
Industry Median: 2.49 vs LTS:0RAG: 4.24

During the past 12 months, Abionyx Pharma's average Book Value Per Share Growth Rate was 72.90% per year. During the past 3 years, the average Book Value Per Share Growth Rate was -3.30% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 2.10% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 11.10% per year.

During the past 11 years, the highest 3-Year average Book Value Per Share Growth Rate of Abionyx Pharma was 686.80% per year. The lowest was -52.30% per year. And the median was -4.70% per year.

Back to Basics: PB Ratio


Abionyx Pharma PB Ratio Historical Data

The historical data trend for Abionyx Pharma's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abionyx Pharma PB Ratio Chart

Abionyx Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.90 3.55 6.30 7.05 5.17

Abionyx Pharma Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.04 7.05 7.35 5.17 4.20

Competitive Comparison of Abionyx Pharma's PB Ratio

For the Biotechnology subindustry, Abionyx Pharma's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Abionyx Pharma's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Abionyx Pharma's PB Ratio distribution charts can be found below:

* The bar in red indicates where Abionyx Pharma's PB Ratio falls into.



Abionyx Pharma PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Abionyx Pharma's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Jun. 2024)
=1.234/0.294
=4.20

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Abionyx Pharma  (LTS:0RAG) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Abionyx Pharma PB Ratio Related Terms

Thank you for viewing the detailed overview of Abionyx Pharma's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Abionyx Pharma Business Description

Traded in Other Exchanges
Address
33-43 Avenue Georges Pompidou-Bat D2, Balma, FRA, 31130
Abionyx Pharma is a new generation biotech company dedicated to the discovery and development of innovative therapies for patients without existing or effective treatment. The biotech assets inherited from CERENIS Therapeutics constitute a portfolio of valuable programs for the treatment of cardiovascular diseases and associated metabolic diseases such as NAFLD and NASH as well as an HDL targeted drug delivery platform in oncology, more specifically in Immuno oncology and chemotherapy.

Abionyx Pharma Headlines

No Headlines